Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity

Blood

Volumn 91, Issue 8, 1998, Pages 2689-2697

  Schattner, Elaine J ^a   Mascarenhas, John ^b   Reyfman, Inna ^b   Koshy, Mary ^b   Woo, Caroline ^b   Friedman, Steven M ^b   Crow, Mary K ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; POKEWEED MITOGEN; TUMOR NECROSIS FACTOR;

ARTICLE; B LYMPHOCYTE ACTIVATION; CHRONIC LYMPHATIC LEUKEMIA; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IRRADIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032523079     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2689.2689_2689_2697     Document Type: Article

References (61)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
2. Gale RP, Caligaris-Cappio F, Dighiero G, Keating M, Montserrat E, Rai K: Recent progress in chronic lymphocytic leukemia. International Workshop on Chronic Lymphocytic Leukemia. Leukemia 8: 1610, 1994
3. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052, 1995
4. O'Brien S, del Giglio A, Keating M: Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85:307, 1995
5. Kipps TJ, Carson DA: Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81:2475, 1993
6. Schroeder HW Jr, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288, 1994
7. Foa R, Catovsky D, Brozovic M, Marsh G, Ooyirilangkumaran T, Cherchi M, Galton DA: Clinical staging and immunological findings in chronic lymphocytic leukemia. Cancer 44:483, 1979
8. Montserrat E, Marques-Pereira JP, Gallart MT, Rozman C: Bone marrow histopathologic patterns and immunologic findings in B-chronic lymphocytic leukemia. Cancer 54:447, 1984
9. Rozman C, Montserrat E, Vinolas N: Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance. Cancer 61:279, 1988
10. Louthrenoo W, Schumacher HR Jr: Listeria monocytogenes osteomyelitis complicating leukemia: Report and literature review of Listeria osteoarticular infections. J Rheumatol 17:107, 1990
11. Kay NE: Abnormal T-cell subpopulation function in CLL: Excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood 57:418, 1981
12. Chiorazzi N, Fu SM, Montazeri G, Kunkel HG, Rai K, Gee T: T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol 122:1087, 1979
13. Perri RT, Kay NE: Abnormal T cell function in early-stage chronic lymphocytic leukemia (CLL) patients. Am J Hematol 22:55, 1986
14. Ayanlar-Batuman O, Ebert E, Hauptman SP: Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety. Blood 67:279, 1986
15. Kishimoto T, Goyert S, Kikutani H, Mason D, Miyasaka M, Moretta L, Ohno T, Okumura K, Shaw S, Springer TA, Sugamura K, Sugawara H, von dem Borne AE, Zola H: Update of CD antigens, 1996. J Immunol 158:3035, 1997
16. Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22:3191, 1992
17. Lederman S, Yellin MJ, Krichevsky A, Belko J, Lee JJ, Chess L: Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175:1091, 1992
18. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543, 1992
19. Covey LR, Cleary AM, Yellin MJ, Ware R, Sullivan G, Belko J, Parker M, Rothman P, Chess L, Lederman S: Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: Identity with the CD40-ligand. Mol Immunol 31:471, 1994
20. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403, 1989
21. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC: Mechanism of antigen-driven selection in germinal centres. Nature 342:929, 1989
22. van Essen D, Kikutani H, Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620, 1995
23. Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152:2163, 1994
24. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12:881, 1994
25. Saeland S, Duvert V, Moreau I, Banchereau J: Human B cell precursors proliferate and express CD23 after CD40 ligation. J Exp Med 178:113, 1993
26. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak-Rothstein A: Protection against Fasdependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163, 1995
27. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557, 1995
28. Ledbetter JA, Shu G, Gallagher M, Clark EA: Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J Immunol 138:788, 1987
29. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA: Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 76:2449, 1990
30. Gruss HJ, Dower SK: Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85:3378, 1995
31. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925, 1993
32. Fu SM, Chiorazzi N, Kunkel HG, Halper JP, Harris SR: Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med 148:1570, 1978
33. Johnstone AP, Jensenius JC, Millard RE, Hudson L: Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes. Clin Exp Immunol 47:697, 1982
34. Dono M, Hashimoto S, Fais F, Trejo V, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Sellars B, Gregersen PK, Ferrarini M, Chiorazzi N: Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood 87:1586, 1996
35. Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826, 1996
36. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063, 1996
37. + T-cell non-Hodgkin's lymphoma. Blood 84:866, 1994
38. Carbone A, Gloghini A, Gruss HJ, Pinto A: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147:912, 1995
39. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE: The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 154:4996, 1995
40. Moses AV, Williams SE, Strussenberg JG, Heneveld ML, Ruhl RA, Bakke AC, Bagby GC, Nelson JA: HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nat Med 3:1242, 1997
41. Yellin MJ, Lee JJ, Chess L, Lederman S: A human CD4-T cell leukemia subclone with contact-dependent helper function. J Immunol 147:3389, 1991
42. Schattner EJ, Yoo D-H, Crow MK, Friedman SM: Superantigen-dependent TH cell/B cell interaction: A model for TH cell-mediated B cell activation and apoptosis, in Zouali M (ed): Human B Cell Superantigens. Austin, TX, R.G. Landes, 1996, p 209
43. Gauchat JF, Aubry JP, Mazzei G, Life P, Jomotte T, Elson G, Bonnefoy JY: Human CD40-ligand: Molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett 315:259, 1993
44. Altin JG, Pagler EB: A one-step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules. Anal Biochem 224:382, 1995
45. Cantwell M, Hua T, Pappas J, Kipps TJ: Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med 3:984, 1997
46. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313, 1992
47. Graf D, Muller S, Korthauer U, van Kooten C, Weise C, Kroczek RA: A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25:1749, 1995
48. Pietravalle F, Lecoanet-Henchoz S, Blasey H, Aubry JP, Elson G, Edgerton MD, Bonnefoy JY, Gauchat JF: Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem 271:5965, 1996
49. Cantwell MJ, Sharma S, Friedmann T, Kipps TJ: Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 88:4676, 1996
50. + T cells derived from patients with chronic lymphocytic leukemia. (submitted)
51. Crawford DH, Catovsky D: In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Immunology 80:40, 1993
52. Fu SM, Chiorazzi N, Kunkel HG: Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev 48:23, 1979
53. Robert KH: PHA-induced soluble factort(s) can activate B-cells from patients with chronic lymphatic leukaemia. Clin Exp Immunol 37:517, 1979
54. Nusslein HG, Dietz A, Burger R, Trag T, Kalden JR, Gramatzki M: Chronic lymphocytic leukemia cells induce non-T cells to produce IgE in the presence of interleukin-4. J Clin Immunol 13:397, 1993
55. Brugnoni D, Rossi G, Tucci A, Cattaneo R, Airo P: Study of CD40 ligand expression in B-cell chronic lymphocytic leukemia. Haematologica 80:440, 1995
56. Cerutti A, Trentin L, Zambello R, Sancetta R, Milani A, Tassinari C, Adami F, Agostini C, Semenzato G: The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J Immunol 157:1854, 1996
57. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, Agostini C, Semenzato G: B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 57:4940, 1997
58. Ranheim EA, Cantwell MJ, Kipps TJ: Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85:3556, 1995
59. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424, 1995
60. Cheng G, Baltimore D: TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev 10:963, 1996
61. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC: CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181, 1995